These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6926388)

  • 1. Assessment of disability in multiple sclerosis a new approach to epidemiological study.
    Beran RG; Jennings VR; Read T
    Clin Exp Neurol; 1981; 18():180-5. PubMed ID: 6926388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
    Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
    J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
    Gray O; McDonnell G; Hawkins S
    Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of performance scales for disability assessment in multiple sclerosis.
    Marrie RA; Goldman M
    Mult Scler; 2007 Nov; 13(9):1176-82. PubMed ID: 17623733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Physical Activity and Disability Survey -- Revised (PADS-R): an evaluation of a measure of physical activity in people with chronic neurological conditions.
    Kayes NM; Schluter PJ; McPherson KM; Taylor D; Kolt GS
    Clin Rehabil; 2009 Jun; 23(6):534-43. PubMed ID: 19447843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
    Roxburgh RH; Seaman SR; Masterman T; Hensiek AE; Sawcer SJ; Vukusic S; Achiti I; Confavreux C; Coustans M; le Page E; Edan G; McDonnell GV; Hawkins S; Trojano M; Liguori M; Cocco E; Marrosu MG; Tesser F; Leone MA; Weber A; Zipp F; Miterski B; Epplen JT; Oturai A; Sørensen PS; Celius EG; Lara NT; Montalban X; Villoslada P; Silva AM; Marta M; Leite I; Dubois B; Rubio J; Butzkueven H; Kilpatrick T; Mycko MP; Selmaj KW; Rio ME; Sá M; Salemi G; Savettieri G; Hillert J; Compston DA
    Neurology; 2005 Apr; 64(7):1144-51. PubMed ID: 15824338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of follow-up and evolution of multiple sclerosis].
    Couvreur G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1143-51. PubMed ID: 11787348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.
    Kern S; Schrempf W; Schneider H; Schultheiss T; Reichmann H; Ziemssen T
    Mult Scler; 2009 Jun; 15(6):752-8. PubMed ID: 19482864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.
    Lobentanz IS; Asenbaum S; Vass K; Sauter C; Klösch G; Kollegger H; Kristoferitsch W; Zeitlhofer J
    Acta Neurol Scand; 2004 Jul; 110(1):6-13. PubMed ID: 15180801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis.
    Snook EM; Motl RW; Gliottoni RC
    Clin Rehabil; 2009 Mar; 23(3):248-58. PubMed ID: 19218299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of multiple sclerosis: quantification by use of scales].
    Izquierdo G; Ruiz-Peña JL
    Rev Neurol; 2003 Jan 16-31; 36(2):145-52. PubMed ID: 12589602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting neuropsychological abnormalities in multiple sclerosis.
    Benedict RH; Zivadinov R
    J Neurol Sci; 2006 Jun; 245(1-2):67-72. PubMed ID: 16626751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in multiple sclerosis.
    Kurtzke JF; Beebe GW; Nagler B; Auth TL; Kurland LT; Nefzger MD
    Trans Am Neurol Assoc; 1973; 98():272-4. PubMed ID: 4784953
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of rehabilitation in multiple sclerosis].
    Miller E
    Pol Merkur Lekarski; 2009 Mar; 26(153):205-7. PubMed ID: 19388533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-rated physical health predicts change in disability in multiple sclerosis.
    Drulovic J; Riise T; Nortvedt M; Pekmezovic T; Manigoda M
    Mult Scler; 2008 Aug; 14(7):999-1002. PubMed ID: 18505776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of eye movement examination and subjective visual vertical in clinical evaluation of multiple sclerosis.
    Serra A; Derwenskus J; Downey DL; Leigh RJ
    J Neurol; 2003 May; 250(5):569-75. PubMed ID: 12736736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
    Goodin DS
    Ann Neurol; 2006 Apr; 59(4):597-605. PubMed ID: 16566022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.